Search clinical trials for: Ruxolitinib
Total 384 results
-
First Affiliated Hospital of Zhejiang UniversityXiangya Hospital of Central South University; Second Affiliated Hospital, School... and other collaboratorsRecruitingHematologic Malignancy | Bronchiolitis Obliterans SyndromeChina
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Julie NangiaIncyte Corporation; Translational Breast Cancer Research ConsortiumActive, not recruitingDuctal Carcinoma in Situ | Lobular Carcinoma in Situ | Atypical Ductal Hyperplasia | Atypical Lobular HyperplasiaUnited States
-
Incyte CorporationCompleted
-
Incyte CorporationCompleted
-
University of ZurichIncyte CorporationNot yet recruitingExanthema | Lichenoid Skin Rashes Under Anti-PD1 Tumor Therapy
-
Beijing Friendship HospitalUnknownHemophagocytic LymphohistiocytosisChina
-
Children's Hospital Medical Center, CincinnatiRecruitingBronchiolitis Obliterans (BO) | Hematopoietic Stem Cell Transplant (HSCT)United States
-
University of JenaCompleted
-
University of Michigan Rogel Cancer CenterCompletedHemophagocytic Syndrome (HPS)United States
-
Margherita MaffioliUnknown
-
University of PittsburghWithdrawnHead and Neck Squamous Cell Carcinoma
-
Children's Hospital Medical Center, CincinnatiRecruitingChronic Graft Versus Host DiseaseUnited States
-
Sichuan UniversityNot yet recruitingGVHD | Acute Stem Cell Transplant ComplicationsChina
-
Multinational Center for Quality of Life Research...Not yet recruiting
-
University of RochesterIncyte CorporationCompletedDiscoid Lupus ErythematosusUnited States
-
Tianjin Medical University General HospitalWithdrawnNeuromyelitis Optica Spectrum Disorder RelapseChina
-
Qilu Hospital of Shandong UniversityCompleted
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis | Post-Polycythemia Vera-MyelofibrosisBelgium, Italy, Spain, Bulgaria, Turkey, Greece, Russian Federation, Austria, Canada, Japan, Germany
-
Kantonsspital AarauNovartis; University Hospital, Basel, Switzerland; Clinical Trial Unit, University...TerminatedCancer CachexiaSwitzerland
-
Novartis PharmaceuticalsNot yet recruitingChronic Graft vs. Host Disease | Graft vs. Host Disease | Corticosteroid-refractory Chronic Graft vs. Host DiseaseChina
-
Memorial Sloan Kettering Cancer CenterIncyte Corporation; BioMed Valley Discoveries, IncRecruitingMyelofibrosisUnited States
-
Stefanie Sarantopoulos, MD, PhD.National Institutes of Health (NIH); Incyte Corporation; Rigel PharmaceuticalsNot yet recruitingChronic Graft Versus Host DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company; Incyte CorporationRecruitingMyelofibrosis Due to and Following Polycythemia VeraUnited States
-
Novartis PharmaceuticalsCompletedGraft vs Host DiseaseJapan, Slovakia, Taiwan, Spain, Korea, Republic of, Thailand, Canada, Russian Federation, Italy, Turkey, India, Czechia, Brazil, Switzerland
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingT-cell Large Granular Lymphocyte Leukemia | T-cell Lymphomas | T-cell Prolymphocytic Leukemia | NK-Cell LymphomasUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Columbia UniversityLocks of Love; Alopecia Areata Initiative - Gates FoundationCompletedAlopecia AreataUnited States
-
Novartis PharmaceuticalsCompletedMyelofibrosisBelgium, Colombia, Canada, Italy, Spain, Austria, Germany, Czechia, Thailand, Hungary, Greece, Argentina, Brazil, Israel, Russian Federation, Mexico, Portugal, South Africa, Tunisia, Slovakia, Saudi Arabia, Poland, Algeria, Ireland, Mor...
-
Incyte CorporationCompletedMyelofibrosisUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingSevere Aplastic Anemia | Single Lineage Cytopenias, T-LGL | Hypoplastic MDSUnited States
-
Qilu Hospital of Shandong UniversityRecruiting
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Thomas Jefferson University; Cornell UniversityRecruiting
-
University of RochesterIncyte CorporationCompleted
-
Children's Hospital Medical Center, CincinnatiCompletedSolid Organ Transplant | Acute-graft-versus-host Disease | Chronic Graft-versus-host-diseaseUnited States
-
Aaron R. MangoldCompletedNecrobiosis LipoidicaUnited States
-
Novartis PharmaceuticalsTerminatedPrimary MyelofibrosisSpain, Germany, Italy
-
Novartis PharmaceuticalsRecruitingSteroid-refractory Acute Graft Versus Host DiseaseChina
-
Novartis PharmaceuticalsRecruitingGraft-versus-Host DiseaseKorea, Republic of
-
Massachusetts General HospitalIncyte CorporationRecruitingPolycythemia Vera | Essential ThrombocythemiaUnited States
-
Massachusetts General HospitalWashington University School of Medicine; Medical College of Wisconsin; Vanderbilt... and other collaboratorsRecruitingAcute Myeloid Leukemia | Allogeneic Stem Cell Transplantation | Acute Myeloid Leukemia in RemissionUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationActive, not recruitingLeukemia | Chronic Myelomonocytic LeukemiaUnited States
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Celgene... and other collaboratorsCompletedIDH2 Mutation | Accelerated/Blast-phase Myeloproliferative Neoplasm | Chronic-phase MyelofibrosisUnited States, Canada
-
Incyte CorporationActive, not recruitingAnemia | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada, Japan, United Kingdom, Italy, France
-
University of California, San FranciscoIncyte CorporationTerminated
-
Yi-Lun WangCompletedSteroid Refractory GVHDTaiwan
-
Incyte CorporationCompleted
-
Philipps University Marburg Medical CenterCompletedCOVID | ARDS, HumanGermany
-
Novartis PharmaceuticalsNovartis is the Marketing Authorization Holder for Jakavi outside the US.No longer availableSevere/Very Severe COVID-19 Illness
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States